Medical Device Network on MSN14h
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout
The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.
JointMedica Announces Launch of IDE Study for Polymotion® Hip Resurfacing System
JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...
Drug Delivery Business16h
Glucotrack expects FDA IDE for implantable CBGM this year
Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this year.
Crain's Chicago Business5d
Abbott's new AFib device gets early OK from European regulators
The company is first rolling out the use of the Volt system among European Union doctors who have already gained experience ...
GlobalData on MSN7d
Abbott eyes intravascular lithotripsy market with clinical trial approval
The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...
Crain's Chicago Business8d
Abbott gets green light for clinical trials of new heart treatment system
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
MassDevice12d
BD treats first patient in study of bioabsorbable scaffold in breast implant revision surgery
BD announced today that investigators treated the first patient in a study of its GalaFlex Lite scaffold system.